Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
- PMID: 7559875
- DOI: 10.1210/jcem.80.10.7559875
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
Abstract
Genetic and environmental factors can modulate the level of sensitivity to various hormones, including estrogens. Enhanced sensitivity to estradiol (E2) has been demonstrated in several biological conditions, such as in sheep during the nonbreeding season, in untreated patients with Turner's syndrome, and in the prepubertal state in normal girls. We postulated that secondary responses to hormonal therapy in patients with breast cancer could also result from enhanced E2 sensitivity, developing as an adaptive mechanism to E2 deprivation. The present study used the MCF-7 human breast cancer cell line as a model system to test the concept that enhanced sensitivity to E2 may occur as a result of adaptation to low E2 levels. After depriving MCF-7 cells of estrogens in tissue culture medium for periods of 1-6 months, we established conditions under which replication could be stimulated maximally by 10(-14)-10(-15) mol/L E2. In contrast, wild-type cells not exposed to estrogen deprivation required 10(-10) mol/L E2 to grow at the same rate. Further, the concentration of the antiestrogen, ICI 164384, needed to inhibit growth by 50% in estrogen-deprived cells was much lower than that required in wild-type cells (i.e. 10(-15) vs. 10(-9) mol/L). Nude mice implanted with these estrogen-deprived cells demonstrated an earlier appearance of palpable tumors in response to E2 than animals bearing wild-type cells. Reexposure to 10(-10)-10(-9) mol/L E2, either in vivo or in vitro, returned these cells to the level of estrogen sensitivity observed in wild-type cells. Taken together, these observations suggest that breast cancer cells can adapt to low levels of estrogens by enhancing their sensitivity to E2.
Similar articles
-
Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.Cancer Res. 1994 Mar 15;54(6):1587-95. Cancer Res. 1994. PMID: 8137264
-
Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.Endocrinology. 2000 Jan;141(1):396-405. doi: 10.1210/endo.141.1.7270. Endocrinology. 2000. PMID: 10614662
-
Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.Cancer Res. 1985 Feb;45(2):584-90. Cancer Res. 1985. PMID: 3967234
-
Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):115-25. doi: 10.1016/s0960-0760(01)00151-0. J Steroid Biochem Mol Biol. 2001. PMID: 11850215 Review.
-
Determinants of tissue estradiol levels and biologic responsiveness in breast tumors.Breast Cancer Res Treat. 1998;49 Suppl 1:S1-7; discussion S33-7. doi: 10.1023/a:1006026732129. Breast Cancer Res Treat. 1998. PMID: 9797011 Review.
Cited by 67 articles
-
Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy.Molecules. 2019 Nov 14;24(22):4120. doi: 10.3390/molecules24224120. Molecules. 2019. PMID: 31739548 Free PMC article.
-
Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells.Breast Cancer (Auckl). 2019 May 15;13:1178223419844198. doi: 10.1177/1178223419844198. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 31205415 Free PMC article.
-
Successful ethinylestradiol therapy for a metastatic breast cancer patient with heavily pre-treated with endocrine therapies.Int Cancer Conf J. 2016 Jan 7;5(3):126-130. doi: 10.1007/s13691-015-0241-7. eCollection 2016 Jul. Int Cancer Conf J. 2016. PMID: 31149439 Free PMC article.
-
Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts.Toxicol Sci. 2019 Jun 1;169(2):380-398. doi: 10.1093/toxsci/kfz054. Toxicol Sci. 2019. PMID: 30796839 Free PMC article.
-
A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.BMC Cancer. 2018 Aug 13;18(1):817. doi: 10.1186/s12885-018-4711-0. BMC Cancer. 2018. PMID: 30103729 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
